In Fight Against Monkeypox, Covid, Indoor Ventilation is a Key Tool in Reducing Risk of Infection

We are facing an ever increasing caseload of Covid-19, which has reached 20,000 new cases every day. There is also an additional threat of monkeypox, which has been detected in India and has been declared a Global Health Emergency. Countries such as India and the UK have even advised airborne precautions pointing towards a risk of easy spread through respiratory droplets. Although, not as easily as Covid-19.

Masks, social distancing and vaccinations are existing tools, which are helping us fight Covid-19 and monkeypox. One important tool that we as a country have not used is indoor ventilation. Indoor ventilation means putting outdoor air inside and removing indoor air to reduce the risk of infection.

India’s Covid data like counting potholes under streetlights. There are far more in the dark

There are two ways to deal with the uncertainties arising from the Covid-19 pandemic. The first is to take them as they come, and as I wrote in an earlier column, deal with the daily developments with a Stoic mind. To play the stroke according to the ball that comes your way. The second way is to try to get a sense of how things are likely to pan out, and prepare for them in advance to the extent possible. To have a game plan, but still be Stoic about it because things might not go the way you want. Most people can choose either way. But those who have to make personal, business or policy decisions that involve a longer horizon need some way to look beyond the here and the now. In other words, we need information that helps us estimate what might happen in the future. And this is where the problem lies.Read More

Modi govt mustn’t hesitate to make Covid vaccine free for Indians. It only costs Rs 80,000 cr

Adar Poonawalla’s recent tweet prompted some discussion on India’s vaccination strategy. The CEO of the Serum Institute of India, one of the world’s largest vaccine manufacturers, asked if “the government of India will have 80,000 crore available, over the next one year” to pay for the purchase and distribution of the Covid-19 vaccine to everyone in the country. My own colleagues estimate that it will cost between Rs 50,000-250,000 crore (depending on the vaccine) to vaccinate 80 percent of India’s population within a year.Read MoreYou can read the article in Hindi here.